• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    LifeLens Technologies Expands Executive Leadership Team and Board of Directors

    11/8/23 7:30:00 AM ET
    $INSP
    $TCMD
    Medical/Dental Instruments
    Health Care
    Medical/Dental Instruments
    Health Care
    Get the next $INSP alert in real time by email

    PHILADELPHIA, Nov. 08, 2023 (GLOBE NEWSWIRE) -- LifeLens Technologies, Inc. (LifeLens), a medical technology company that provides real-time physiological monitoring, today announced the appointment of three industry veterans to the following positions on its executive leadership team and Board of Directors:

    • Daniel J. Sullivan, Chairman of the Board of LifeLens, as Chief Executive Officer
    • Brent A. Moen as Chief Financial Officer
    • Richard J. Buchholz as a member of the Board of Directors

    "With LifeLens, we have a significant opportunity to disrupt healthcare and make a meaningful impact on patients and healthcare professionals, and we are thrilled to have Brent and Rick join the LifeLens team," said Dan Sullivan, Chief Executive Officer and Chairman of the Board of Directors of LifeLens. "Brent and Rick collectively bring over 60 years of combined experience and track records that have led to business growth while transforming clinical care, and now their skills will help enable LifeLens to realize its potential."  

    Daniel Sullivan has served as Chairman of the Board of Directors of LifeLens and assumed the additional role of Chief Executive Officer of LifeLens effective January 2023. Mr. Sullivan brings over 40 years of leadership in the medical device industry where he has been a principal, chief executive officer, board member or co-founder of 11 separate start-up companies, 10 of which have been acquired. These companies include SciMed Life Systems, Inc., which was acquired by Boston Scientific Corporation in 1995, The WATCHMAN (Atritech, Inc.), which was acquired by Boston Scientific Corporation in 2011, superDimension, Ltd., which was acquired by Covidien plc in 2012 and NeuWave Medical, Inc., which was acquired by Johnson & Johnson in 2016.

    Brent Moen was appointed to the position of Chief Financial Officer effective September 2023 and has over 30 years of experience in finance. Mr. Moen most recently served as the Chief Financial Officer of Tactile Systems Technology, Inc. (NASDAQ:TCMD), a publicly traded medical device company, from September 2018 until March 2023. Prior to joining Tactile Systems Technology, Mr. Moen served as Chief Financial Officer of Entellus Medical, Inc., a publicly traded medical device company, from 2016 until its acquisition by Stryker Corporation in 2018. Mr. Moen also served as the Chief Financial Officer of ABRA Auto Body & Glass LP, as well as the Chief Financial Officer of Regis Corporation.

    Richard Buchholz was appointed to the LifeLens' Board of Directors, effective October 2023. Since 2014, Mr. Buchholz has served as the Chief Financial Officer of Inspire Medical Systems, Inc. (NYSE:INSP), a global leader in the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Prior to joining Inspire, Mr. Buchholz served as the Chief Financial Officer at superDimension, Ltd. from 2006 to 2013. Mr. Buchholz also served as the Chief Financial Officer of Vascular Solutions, Inc., which was acquired by Teleflex Incorporated in 2017.

    About LifeLens Technologies, Inc.

    LifeLens, a private healthcare company, has developed a revolutionary system incorporating artificial intelligence capable of monitoring physiological data to assess real-time health readiness and performance. The LifeLens system can provide monitoring both remotely and, in the hospital, or doctors' office and can wirelessly transmit real‐time scenarios providing actionable information that will allow health professionals to make data-driven decisions to improve the health and welfare of patients. The LifeLens product is FDA-cleared for the indication of remote single channel electrocardiogram (ECG) and heart rate monitoring. The system is not yet FDA cleared for other indications.

    Since 2019, LifeLens has been testing its wearable physiological sensors with the United States Armed Forces, allowing military leaders the ability to monitor their troops health, readiness, and performance in real-time training and operational environments. For more information, please visit www.lifelenstech.com.

    Inquiries:

    Dan Sullivan, CEO

    [email protected]

    Brent Moen, CFO

    [email protected]



    Primary Logo

    Get the next $INSP alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $INSP
    $TCMD

    CompanyDatePrice TargetRatingAnalyst
    Tactile Systems Technology Inc.
    $TCMD
    5/6/2025$14.00Overweight → Neutral
    Piper Sandler
    Tactile Systems Technology Inc.
    $TCMD
    2/19/2025$23.00 → $18.00Buy → Neutral
    B. Riley Securities
    Inspire Medical Systems Inc.
    $INSP
    11/20/2024$220.00 → $255.00Neutral → Buy
    BofA Securities
    Tactile Systems Technology Inc.
    $TCMD
    11/5/2024Outperform → Perform
    Oppenheimer
    Tactile Systems Technology Inc.
    $TCMD
    11/5/2024Buy → Neutral
    BTIG Research
    Tactile Systems Technology Inc.
    $TCMD
    9/26/2024$23.00Buy
    B. Riley Securities
    Inspire Medical Systems Inc.
    $INSP
    5/8/2024$265.00 → $225.00Buy → Neutral
    BofA Securities
    Inspire Medical Systems Inc.
    $INSP
    4/19/2024$285.00Outperform
    RBC Capital Mkts
    More analyst ratings

    $INSP
    $TCMD
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Inspire Medical Systems, Inc. to Report Second Quarter 2025 Financial Results on August 4, 2025

      MINNEAPOLIS, July 07, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE:INSP) (Inspire) will release financial results for the second quarter 2025 after the close of trading on Monday, August 4. Inspire's management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments. A webcast of the call will be accessible via the Investor Relations page of the Inspire website or through this link: Inspire's Q2 2025 earnings call webcast. For those not planning to ask a question of management, the Company recommends listening via the webcast. If you plan to ask a question, please use the followin

      7/7/25 8:00:00 AM ET
      $INSP
      Medical/Dental Instruments
      Health Care
    • New Data Demonstrates Significant Clinical and Quality-of-Life Benefits of Flexitouch® Plus in Treating Lymphedema Among Head and Neck Cancer Survivors

      MINNEAPOLIS, June 03, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. ("Tactile Medical"; the "Company") (NASDAQ:TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the presentation of new clinical data at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting that demonstrates significant clinical and quality-of-life benefits associated with use of the Company's Flexitouch Plus versus usual care in treating patients with head and neck cancer-related lymphedema. "Current modalities for managing head and neck cancer-related lymphedema include therapist guided lymphedema treatment and lifelong home-based self-car

      6/3/25 8:00:00 AM ET
      $TCMD
      Medical/Dental Instruments
      Health Care
    • Inspire Medical Systems, Inc. to Present at the Truist Securities MedTech Conference

      MINNEAPOLIS, June 03, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE:INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Truist Securities MedTech Conference on Tuesday, June 17, 2025. Inspire is scheduled to present at 11:20 a.m. Eastern Time. The presentation will be accessible via a live webcast here. A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire's Investor website at https://investors.inspiresl

      6/3/25 8:00:00 AM ET
      $INSP
      Medical/Dental Instruments
      Health Care

    $INSP
    $TCMD
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    See more
    • March 21, 2023 - FDA Roundup: March 21, 2023

      For Immediate Release: March 21, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA completed its second pre-market consultation for a human food made from cultured animal cells. The firm will use animal cell culture technology to take living cells from chickens and grow the cells in a controlled environment to make the cultured

      3/21/23 3:12:46 PM ET
      $INSP
      Medical/Dental Instruments
      Health Care

    $INSP
    $TCMD
    Financials

    Live finance-specific insights

    See more
    • Inspire Medical Systems, Inc. to Report Second Quarter 2025 Financial Results on August 4, 2025

      MINNEAPOLIS, July 07, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE:INSP) (Inspire) will release financial results for the second quarter 2025 after the close of trading on Monday, August 4. Inspire's management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments. A webcast of the call will be accessible via the Investor Relations page of the Inspire website or through this link: Inspire's Q2 2025 earnings call webcast. For those not planning to ask a question of management, the Company recommends listening via the webcast. If you plan to ask a question, please use the followin

      7/7/25 8:00:00 AM ET
      $INSP
      Medical/Dental Instruments
      Health Care
    • Tactile Systems Technology, Inc. Reports First Quarter 2025 Financial Results

      MINNEAPOLIS, May 05, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. ("Tactile Medical"; the "Company") (NASDAQ:TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the first quarter ended March 31, 2025. First Quarter 2025 Summary & Recent Business Highlights: Total revenue increased 0.3% year-over-year to $61.3 millionGross margin of 74% versus 71% in Q1 2024Net loss of $3.0 million versus $2.2 million in Q1 2024Adjusted EBITDA loss of $0.3 million versus positive Adjusted EBITDA of $1.0 million in Q1 2024Repurchased $10.0 million of stock under the Company's share repurchase programExpanded launch of

      5/5/25 4:05:00 PM ET
      $TCMD
      Medical/Dental Instruments
      Health Care
    • Inspire Medical Systems, Inc. Announces First Quarter 2025 Financial Results and Updates 2025 Outlook

      Inspire Reports Year-over-Year Revenue Growth of 23% and Earnings per Share of $0.10 in the First Quarter MINNEAPOLIS, May 05, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE:INSP) (Inspire, or the company), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today reported financial results for the quarter ended March 31, 2025. Recent Business Highlights Generated revenue of $201.3 million in the first quarter of 2025, a 23% increase over the same quarter last yearAchieved gross margin of 84.7% in the first quarter of 2025Generated earnings per share of $0.10 in

      5/5/25 4:02:00 PM ET
      $INSP
      Medical/Dental Instruments
      Health Care

    $INSP
    $TCMD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Sparks Charisse Y bought $15,350 worth of shares (100 units at $153.50), increasing direct ownership by 11% to 998 units (SEC Form 4)

      4 - Inspire Medical Systems, Inc. (0001609550) (Issuer)

      1/24/24 4:32:03 PM ET
      $INSP
      Medical/Dental Instruments
      Health Care

    $INSP
    $TCMD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Tactile Systems downgraded by Piper Sandler with a new price target

      Piper Sandler downgraded Tactile Systems from Overweight to Neutral and set a new price target of $14.00

      5/6/25 8:04:03 AM ET
      $TCMD
      Medical/Dental Instruments
      Health Care
    • Tactile Systems downgraded by B. Riley Securities with a new price target

      B. Riley Securities downgraded Tactile Systems from Buy to Neutral and set a new price target of $18.00 from $23.00 previously

      2/19/25 7:05:55 AM ET
      $TCMD
      Medical/Dental Instruments
      Health Care
    • Inspire Medical Systems upgraded by BofA Securities with a new price target

      BofA Securities upgraded Inspire Medical Systems from Neutral to Buy and set a new price target of $255.00 from $220.00 previously

      11/20/24 7:43:58 AM ET
      $INSP
      Medical/Dental Instruments
      Health Care

    $INSP
    $TCMD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Mccormick Shawn exercised 4,000 shares at a strike of $16.00, increasing direct ownership by 17% to 28,046 units (SEC Form 4)

      4 - Inspire Medical Systems, Inc. (0001609550) (Issuer)

      6/6/25 6:06:02 PM ET
      $INSP
      Medical/Dental Instruments
      Health Care
    • Officer Rondoni John sold $259,025 worth of shares (1,734 units at $149.38), decreasing direct ownership by 11% to 13,766 units (SEC Form 4)

      4 - Inspire Medical Systems, Inc. (0001609550) (Issuer)

      5/21/25 4:05:14 PM ET
      $INSP
      Medical/Dental Instruments
      Health Care
    • Chief Financial Officer Birkemeyer Elaine M. sold $29,037 worth of shares (2,921 units at $9.94), decreasing direct ownership by 3% to 99,111 units (SEC Form 4)

      4 - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Issuer)

      5/14/25 5:26:59 PM ET
      $TCMD
      Medical/Dental Instruments
      Health Care

    $INSP
    $TCMD
    SEC Filings

    See more
    • Inspire Medical Systems Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Inspire Medical Systems, Inc. (0001609550) (Filer)

      6/13/25 6:19:04 AM ET
      $INSP
      Medical/Dental Instruments
      Health Care
    • SEC Form SD filed by Tactile Systems Technology Inc.

      SD - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Filer)

      5/30/25 4:48:49 PM ET
      $TCMD
      Medical/Dental Instruments
      Health Care
    • SEC Form SD filed by Inspire Medical Systems Inc.

      SD - Inspire Medical Systems, Inc. (0001609550) (Filer)

      5/30/25 4:12:28 PM ET
      $INSP
      Medical/Dental Instruments
      Health Care

    $INSP
    $TCMD
    Leadership Updates

    Live Leadership Updates

    See more
    • Inspire Medical Systems, Inc. Announces the Addition of Paul T. Hoff, M.D., M.S. and Ruchir P. Patel, M.D., F.A.C.P. as Vice President, Senior Medical Directors

      MINNEAPOLIS, April 21, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE:INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), today announced that two leading physicians in the field of sleep medicine and sleep surgery, Paul T. Hoff, M.D., M.S., an otolaryngologist, and Ruchir P. Patel, M.D., F.A.C.P., a sleep medicine specialist, will join Inspire in Vice President, Senior Medical Director roles, effective April 21 and June 2 respectively.   "Dr. Hoff and Dr. Patel are widely regarded as experts and thought leaders in their respective fields, a

      4/21/25 8:00:00 AM ET
      $INSP
      Medical/Dental Instruments
      Health Care
    • Tactile Medical Appoints Laura King to Board of Directors

      MINNEAPOLIS, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. ("Tactile Medical") (NASDAQ:TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the appointment of Laura King to the Company's Board of Directors ("Board") and as a member of the Audit and Compliance & Reimbursement Committees, effective January 13, 2025. Ms. King is a seasoned healthcare executive with a proven track record of leadership and developing innovative products that enhance patient care. Her extensive experience includes a 22-year career at General Electric Company (GE), where she served as a Company Officer in her role as President & CEO of GE

      1/13/25 8:00:00 AM ET
      $TCMD
      Medical/Dental Instruments
      Health Care
    • Presidio Medical™ Announces Appointment of Richard J. Buchholz to Join its Board of Directors

      Presidio Medical, Inc., a clinical stage company developing a transformational neuromodulation platform, is pleased to announce Richard J. Buchholz will join its Board of Directors. Rick is the Chief Financial Officer of Inspire Medical Systems, Inc. (NYSE:INSP), where he has played a pivotal role in driving strategic financial and operational growth for the global leader in the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. "We are excited that Rick is joining the Board of Directors of Presidio Medical at this critical time in our company's journey. His leadership and financial acumen will be instrumental in advanc

      12/5/24 12:12:00 PM ET
      $INSP
      Medical/Dental Instruments
      Health Care

    $INSP
    $TCMD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Tactile Systems Technology Inc.

      SC 13G/A - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Subject)

      11/13/24 7:29:11 PM ET
      $TCMD
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G filed by Tactile Systems Technology Inc.

      SC 13G - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Subject)

      11/13/24 5:04:27 PM ET
      $TCMD
      Medical/Dental Instruments
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Inspire Medical Systems Inc.

      SC 13G/A - Inspire Medical Systems, Inc. (0001609550) (Subject)

      11/12/24 10:32:14 AM ET
      $INSP
      Medical/Dental Instruments
      Health Care